About 7% of 7,252 nonduplicated clinical Escherichia coli strains from a Spanish hospital showed reduced susceptibility to amoxicillin-clavulanate. Of these, 0.37% produced the IRTs TEM-30, TEM-31, TEM-33, TEM-34, TEM-37, TEM-40, TEM-51, and TEM-54; 5.3% were probable class C β-lactamase overproducers; 0.8% were probable TEM-1 hyperproducers; 0.18% produced OXA-30; 0.15% overexpressed SHV-1; and 0.03% produced a PSE-1 enzyme.
|Journal||Antimicrobial Agents and Chemotherapy|
|Publication status||Published - 1 Dec 2002|
Miró, E., Navarro, F., Mirelis, B., Sabaté, M., Rivera, A., Coll, P., & Prats, G. (2002). Prevalence of clinical isolates of Escherichia coli producing inhibitor-resistant β-lactamases at a University Hospital in Barcelona, Spain, over a 3-year period. Antimicrobial Agents and Chemotherapy, 46, 3991-3994. https://doi.org/10.1128/AAC.46.12.3991-3994.2002